HKD 0.62
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 193.75 Million CNY | 545.85% |
2022 | 30 Million CNY | 662.78% |
2021 | 3.93 Million CNY | -34.36% |
2020 | 5.99 Million CNY | -99.53% |
2019 | 1.26 Billion CNY | 58945.77% |
2018 | 2.15 Million CNY | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 180 Million CNY | 0.0% |
2023 Q4 | 193.75 Million CNY | 0.0% |
2023 FY | 193.75 Million CNY | 545.85% |
2023 Q2 | 107.88 Million CNY | 0.0% |
2022 FY | 30 Million CNY | 662.78% |
2022 Q4 | 33.68 Million CNY | 0.0% |
2022 Q2 | 20.95 Million CNY | 0.0% |
2021 Q2 | 7.82 Million CNY | 0.0% |
2021 FY | 3.93 Million CNY | -34.36% |
2021 Q4 | 3.93 Million CNY | 0.0% |
2020 Q2 | 1.73 Billion CNY | 0.0% |
2020 FY | 5.99 Million CNY | -99.53% |
2020 Q4 | 5.99 Million CNY | 0.0% |
2019 Q2 | - HKD | 0.0% |
2019 Q4 | 1.42 Billion CNY | 0.0% |
2019 FY | 1.26 Billion CNY | 58945.77% |
2018 FY | 2.15 Million CNY | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | 30.61 Million HKD | -532.938% |
CK Life Sciences Int'l., (Holdings) Inc. | 4.27 Billion HKD | 95.466% |